Citigroup
SLS icon

Citigroup’s SELLAS Life Sciences SLS Stock Holding History

Citigroup’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10
Closed -$1K – 7787
2018
Q4 		$1K Hold
10
– – ﹤0.01% 7593
2018
Q3 		$1K Hold
10
– – ﹤0.01% 7679
2018
Q2 		$2K Hold
10
– – ﹤0.01% 7474
2018
Q1 		$2K Buy
+10
New +$2.85K ﹤0.01% 7377
2017
Q4 		– Sell
-15
Closed -$8K – 7640
2017
Q3 		$8K Hold
15
– – ﹤0.01% 6756
2017
Q2 		$13K Sell
15
-1
-6% -$870 ﹤0.01% 6442
2017
Q1 		$14K Buy
16
+4
+33% +$6.62K ﹤0.01% 6429
2016
Q4 		$34K Buy
+12
New +$69.8K ﹤0.01% 6316

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM